Benefits of cyclosporine microemulsion (Neoral) C2 monitoring are sustained at 1 year in de novo liver transplant recipients

This publication has 4 references indexed in Scilit:

• PEAK CYCLOSPORINE LEVELS (Cmax) CORRELATE WITH FREEDOM FROM LIVER GRAFT REJECTION
  Transplantation, 1999
• Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome †
  Hepatology, 1998
• NEORAL COMPARED TO SANDIMMUNE IS ASSOCIATED WITH A DECREASE IN HISTOLOGIC SEVERITY OF REJECTION IN PATIENTS UNDERGOING PRIMARY LIVER TRANSPLANTATION1
  Transplantation, 1997
• Improved Dose Linearity of Cyclosporine Pharmacokinetics from a Microemulsion Formulation
  Pharmaceutical Research, 1994